• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
A20010017 布地奈德/福莫特罗吸入粉雾剂 budesonide;formoterol fumarate Inhalation Chemical Drugs New Drug Application 2001-05-11 阿斯特拉(无锡)制药有限公司 Astrazeneca Pharmaceutical Co Ltd Approval Completed-Pending Certificated 2003-01-24 view
CXLB00010 布地奈德/福莫特罗复方粉雾吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs(3) New Drug Application 2000-11-24 北京阿里斯临床研究有限公司 In Approval view
JYHL2100002 布地奈德福莫特罗吸入粉雾剂 budesonide;formoterol fumarate Inhalation Chemical Drugs(5.2) Import Drug Application 2021-02-11 Orion Corporation In Review 2021-02-11 view
JYHL2100001 布地奈德福莫特罗吸入粉雾剂 budesonide;formoterol fumarate Inhalation Chemical Drugs(5.2) Import Drug Application 2021-02-11 Orion Corporation In Review 2021-02-11 view
JYHL2100003 布地奈德福莫特罗吸入粉雾剂 budesonide;formoterol fumarate Inhalation Chemical Drugs(5.2) Import Drug Application 2021-02-11 Orion Corporation In Review 2021-02-11 view
JTH2400027 布地奈德福莫特罗吸入粉雾剂安慰剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Disposable Import Drug Application 2024-02-29 view
CXHL2300939 布地奈德福莫特罗吸入粉雾剂(胶囊型) budesonide;formoterol fumarate Inhalation Chemical Drugs(2.2) New Drug Application 2023-09-01 Zhuhai Resproly Pharmaceutical Technology Co Ltd view
JYHB1701492 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-11-29 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-02-02 view
JYHB1000455 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2010-06-03 AstraZeneca AB AstraZeneca AB Certificate Issued 2013-04-16 view
J0400059 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2004-06-11 AstraZeneca AB (A wholly owned subsidiary company of AstraZeneca UK Ltd.) AstraZeneca AB Pending Approval 2005-01-24 view
JYHB1800531 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2018-05-10 AstraZeneca AB AstraZeneca AB Certificate Issued 2018-07-10 view
JYHB1501912 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2015-12-14 AstraZeneca AB AstraZeneca AB Certificate Issued 2019-07-01 view
JXHL0700010 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs(3.4) Import Drug Application 2007-01-18 AstraZeneca AB AstraZeneca AB Certificate Issued 2009-02-12 view
JYHB1701271 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-09-30 AstraZeneca AB AstraZeneca AB Filed 2017-10-13 view
JYHB0901101 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2010-01-14 AstraZeneca AB AstraZeneca AB Filed 2010-05-21 view
JYHB1701500 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-12-13 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-03-20 view
JXHL1400062 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Import Drug Application 2014-03-12 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Certificate Issued 2015-04-20 view
JYHB0500728 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2005-11-09 Draco Lakemedel AB Draco Lakemedel AB Certificate Issued 2006-03-23 view
JYHB1601706 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2016-12-30 AstraZeneca AB AstraZeneca AB Certificate Issued 2017-05-10 view
JXHS0800025 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Import Drug Application 2008-05-05 AstraZeneca AB AstraZeneca AB Certificate Issued 2009-10-16 view